MIRA INFORM REPORT
|
Report No. : |
336381 |
|
Report Date : |
12.08.2015 |
IDENTIFICATION DETAILS
|
Name : |
MARKSANS PHARMA LIMITED (w.e.f. 08.11.2005) |
|
|
|
|
Formerly Known
As : |
TASC PHARMACEUTICALS LIMITED |
|
|
|
|
Registered
Office : |
11th Floor, |
|
Tel. No.: |
91-22-40012000 |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as
on) : |
31.03.2015 |
|
|
|
|
Date of
Incorporation : |
16.04.1992 |
|
|
|
|
Com. Reg. No.: |
11-066364 |
|
|
|
|
Capital
Investment / Paid-up Capital : |
Rs.534.310 Million |
|
|
|
|
CIN No.: [Company Identification
No.] |
L24110MH1992PLC066364 |
|
|
|
|
IEC No.: |
0394012054 |
|
|
|
|
TAN No.: [Tax Deduction &
Collection Account No.] |
MUMT09972E |
|
|
|
|
PAN No.: [Permanent Account No.] |
AAACT3153G |
|
|
|
|
Legal Form : |
A Public Limited Liability Company. The company’s Shares are Listed on
the Stock Exchanges. |
|
|
|
|
Line of Business
: |
Manufacturing and marketing of pharmaceutical formulations. |
|
|
|
|
No. of Employees
: |
436 (Approximately) |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba (53) |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Good |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Exist |
|
|
|
|
Comments : |
Subject is an established company having a fine track record. Financial position of the company seems to be decent. Trade relations are reported as fair. Business is active. Payment
terms are reported to be regular and as per commitment. The company can be considered normal for business dealings at usual
trade terms and conditions. |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
EXTERNAL AGENCY RATING
|
Rating Agency Name |
Fitch Rating |
|
Rating |
Long term issuer rating= “IND A-“ |
|
Rating Explanation |
Have adequate degree of safety and carry low
credit risk. |
|
Date |
04.07.2014 |
|
Rating Agency Name |
Fitch Rating |
|
Rating |
Non-fund based limits= “IND A1” |
|
Rating Explanation |
Have very strong degree of safety and carry
lowest credit risk. |
|
Date |
04.07.2014 |
RBI DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available RBI Defaulters’ list.
EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter in
the publicly available EPF (Employee Provident Fund) Defaulters’ list as of
31-03-2013.
INFORMATION DENIED
Management Non Co-operative (91-22-40012000)
LOCATIONS
|
Registered Office / Corporate Office : |
11th Floor, Lotus Business Park, Off New Link Road, Andheri
(West), Mumbai – 400053, Maharashtra, India |
|
Tel. No.: |
91-22-40012000 (30 lines) |
|
Fax No.: |
91-22-40012099 / 40012011 |
|
E-Mail : |
|
|
Website : |
|
|
|
Owned |
|
|
|
|
Branch Office : |
F-89/13, 2nd Floor, Okhla Industrial Area, Phase 1, |
|
|
|
|
Factory 1 : |
L – 82 and 83, Verna Industrial Estate, Verna, Goa – 403722, India |
|
Tel. No.: |
91-832-2782017 / 2782512 / 2782678 |
|
Fax No.: |
91-832-2782071 |
|
Location : |
Owned |
|
|
|
|
Factory 2 : |
Bell, Sons and Company (Druggists) Limited, Gifford House, Slaidburn
Crescent, Southport, Merseyside. PR9 9AL |
DIRECTORS
AS ON 31.03.2014
|
Name : |
Mr. Mark Saldanha |
|
Designation : |
Chairman and Managing Director |
|
|
|
|
Name : |
Dr. Balwant S. Desai |
|
Designation : |
Whole-time Director |
|
|
|
|
Name : |
Mr. Seetharama S. Buddharaju |
|
Designation : |
Director |
|
|
|
|
Name : |
Mr. Naresh B. Wadhwa |
|
Designation : |
Director |
|
|
|
|
Name : |
Mr. Ajay S. Joshi |
|
Designation : |
Director |
KEY EXECUTIVES
|
Name : |
Mr. Jitendra Sharma |
|
Designation : |
Chief Financial Officer |
|
|
|
|
Name : |
Mr. Harshavardhan Panigrahi |
|
Designation : |
Company Secretary and Manager - Legal |
SHAREHOLDING PATTERN
AS ON 30.06.2015
|
Category of
Shareholder |
No. of Shares |
Percentage
of Holding |
|
(A) Shareholding of Promoter and Promoter Group |
|
|
|
(1) Indian |
|
|
|
|
197491733 |
48.25 |
|
|
197491733 |
48.25 |
|
|
|
|
|
Total shareholding of Promoter and Promoter Group (A) |
197491733 |
48.25 |
|
(B) Public Shareholding |
|
|
|
|
|
|
|
|
1051919 |
0.26 |
|
|
333181 |
0.08 |
|
|
59498457 |
14.54 |
|
|
60883557 |
14.87 |
|
|
|
|
|
|
18194218 |
4.45 |
|
|
|
|
|
Individual shareholders holding nominal share capital up
to Rs.0.100 million |
79114357 |
19.33 |
|
Individual shareholders holding nominal share capital in
excess of Rs.0.100 million |
44688637 |
10.92 |
|
|
8941196 |
2.18 |
|
|
2361724 |
0.58 |
|
|
4399518 |
1.07 |
|
|
4000 |
0.00 |
|
|
1201265 |
0.29 |
|
|
974689 |
0.24 |
|
|
150938408 |
36.88 |
|
Total Public shareholding (B) |
211821965 |
51.75 |
|
Total (A)+(B) |
409313698 |
100.00 |
|
(C) Shares held by Custodians and against which Depository
Receipts have been issued |
0 |
0.00 |
|
|
0 |
0.00 |
|
|
0 |
0.00 |
|
|
0 |
0.00 |
|
Total (A)+(B)+(C) |
409313698 |
0.00 |
Shareholding of securities (including shares, warrants,
convertible securities) of persons belonging to the category Promoter and
Promoter Group
|
Category of
Shareholder |
No. of Shares |
Percentage
of Holding |
|
Mark Saldanha |
19,74,91,553 |
48.25 |
|
Sandra Saldanha |
180 |
0.00 |
|
Total |
19,74,91,733 |
48.25 |
Shareholding of securities (including shares, warrants, convertible
securities) of persons belonging to the category Public and holding more than
1% of the total number of shares
|
Category of
Shareholder |
No. of Shares |
Percentage
of Holding |
|
Wasatch Emerging Markets Small Cap Fund |
9077487 |
2.22 |
|
Mondrian Emerging Markets Small Cap Equity Fund L.P. |
9641623 |
2.36 |
|
Ontario Pension Board-Mondrian Investment Partners Ltd |
4644246 |
1.13 |
|
Total |
23363356 |
5.71 |
Details of Locked-in Shares
|
Category of
Shareholder |
No. of Shares |
Percentage
of Holding |
|
Mark Saldanha |
1,75,00,000 |
4.28 |
|
Total |
1,75,00,000 |
4.28 |
BUSINESS DETAILS
|
Line of Business : |
Manufacturing and marketing of pharmaceutical formulations. |
|
|
|
|
Products : |
Pharmaceutical Formulations |
|
|
|
|
Brand Names : |
Not Divulged |
|
|
|
|
Agencies Held : |
Not Divulged |
|
|
|
|
Exports : |
Not Divulged |
|
|
|
|
Imports : |
Not Divulged |
|
|
|
|
Terms : |
|
|
Selling : |
Not Divulged |
|
|
|
|
Purchasing : |
Not Divulged |
PRODUCTION STATUS – NOT AVAILABLE
GENERAL INFORMATION
|
Suppliers : |
|
|||||||||||||||||||||||||||
|
|
|
|||||||||||||||||||||||||||
|
Customers : |
|
|||||||||||||||||||||||||||
|
|
|
|||||||||||||||||||||||||||
|
No. of Employees : |
436 (Approximately) |
|||||||||||||||||||||||||||
|
|
|
|||||||||||||||||||||||||||
|
Bankers : |
· State Bank of India · Bank of India · Corporation Bank |
|||||||||||||||||||||||||||
|
|
|
|||||||||||||||||||||||||||
|
Facilities : |
|
|
Statutory Auditors
: |
N. K. Mittal and Associates Chartered Accountants |
|
|
|
|
Legal Advisors : |
Crawford Bayley and Company |
|
|
|
|
Collaborators : |
Not Divulged |
|
|
|
|
Membership : |
Not Divulged |
|
|
|
|
Subsidiary
Companies (As on 31.03.2014) : |
|
CAPITAL STRUCTURE
AS ON 31.03.2015
Authorised Capital : Not Available
Issued, Subscribed & Paid-up Capital : Rs.534.310 Million
AS ON 31.03.2014
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
550000000 |
Equity Shares |
Re.1/- each |
Rs.550.000 Million |
|
1400000 |
7% Redeemable Cumulative Preference Shares |
Rs.100/- each |
Rs.140.000 Million |
|
|
|
|
|
|
|
Total
|
|
Rs.690.000
Million |
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
385307204 |
Equity Shares |
Re.1/- each |
Rs.385.307
Million |
|
1350000 |
7% Redeemable Cumulative Preference Shares |
Rs.100/- each |
Rs.135.000
Million |
|
|
|
|
|
|
|
Total |
|
Rs.520.307 Million |
a. Reconciliation of the shares outstanding at
the beginning and at the end of the reporting period
|
Particulars |
Equity Shares of Re. 1 each |
7%
Redeemable Cumulative
Preference Shares of Rs.100/- each |
||
|
|
Numbers |
Rs. in Million |
Numbers |
Rs. in Million |
|
Shares outstanding at the beginning of the year |
385307204 |
385.307 |
1350000 |
135.000 |
|
Shares Issued during the year |
-- |
-- |
-- |
-- |
|
Shares bought back during the year |
-- |
-- |
-- |
-- |
|
Shares outstanding at the end of the year |
385307204 |
385.307 |
1350000 |
135.000 |
b. Terms/rights attached to Equity Shares
The Company has only one class of Equity Shares having a par value of Re.1/- per share. All the Equity Shares rank pari passu in all respect. Each holder of Equity Shares is entitled to one vote per share. The equity shareholders are entitled to dividend, if declared by the shareholders in an Annual General Meeting, in proportion to the number of Equity Shares held by the shareholders.
In the event of liquidation of the Company, the holders of Equity Shares will be entitled to receive remaining assets of the Company, after distribution of all preferential amounts. The distribution will be in proportion to the number of Equity Shares held by the shareholders.
c. Terms/rights attached to Preference Shares
The Company has issued 1,350,000 7% Redeemable Cumulative Preference Shares of Rs.100/- each fully paid-up to Glenmark Pharmaceuticals Limited on 27th March, 2013 against redemption of 1,350,000 7% Redeemable Cumulative Preference Shares of Rs.100/- each issued on 27.03.2008. These new preference shares will be due for redemption on 27th March, 2018. These preference shares carry dividend at the rate of 7% per annum subject to approval of the shareholders at an Annual General Meeting.
The holder of the preference shares is entitled to one vote per share only on resolutions placed before the Company which directly affect the rights attached to the preference shares. In the event of liquidation of the Company before redemption of the preference shares, the holder of the preference shares will have priority over equity shares in the payment of dividend and repayment of capital.
d. The company has not issued bonus shares and shares for consideration other than cash nor has the company bought back any shares during the period of five years immediately preceding the reporting date except the issue of preference shares as stated in Note.
e. Details of shareholders holding more than
5% shares in the Company
|
Name of Shareholder |
As on 31.03.2014 |
|
|
|
No. of Shares |
% of Holding |
|
Equity Shares of
Re. 1/- each fully paid |
|
|
|
Mr. Mark
Saldanha |
197491553 |
51.25 |
|
7% Redeemable
Cumulative Preference Shares of Rs. 100/- each fully paid |
|
|
|
Glenmark
Pharmaceuticals Limited |
1350000 |
100.00 |
FINANCIAL DATA
[all figures are
in Rupees Million]
ABRIDGED
BALANCE SHEET
|
SOURCES OF FUNDS |
31.03.2015 |
31.03.2014 |
31.03.2013 |
|
I.
EQUITY
AND LIABILITIES |
|
|
|
|
(1)Shareholders' Funds |
|
|
|
|
(a) Share Capital |
534.310 |
520.307 |
520.307 |
|
(b) Reserves & Surplus |
3047.460 |
1078.892 |
579.456 |
|
(c) Money
received against share warrants |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
(2) Share Application money pending
allotment |
0.000 |
0.000 |
0.000 |
|
Total
Shareholders’ Funds (1) + (2) |
3581.770 |
1599.199 |
1099.763 |
|
|
|
|
|
|
(3)
Non-Current Liabilities |
|
|
|
|
(a) long-term borrowings |
0.000 |
198.154 |
78.768 |
|
(b) Deferred tax liabilities (Net) |
5.030 |
18.678 |
22.213 |
|
(c) Other long term
liabilities |
0.000 |
0.000 |
0.000 |
|
(d) long-term
provisions |
0.000 |
0.000 |
0.000 |
|
Total Non-current
Liabilities (3) |
5.030 |
216.832 |
100.981 |
|
|
|
|
|
|
(4)
Current Liabilities |
|
|
|
|
(a) Short
term borrowings |
435.220 |
580.587 |
753.123 |
|
(b) Trade
payables |
445.820 |
405.045 |
298.594 |
|
(c) Other
current liabilities |
398.810 |
735.860 |
750.516 |
|
(d) Short-term
provisions |
404.480 |
226.780 |
99.499 |
|
Total Current
Liabilities (4) |
1684.330 |
1948.272 |
1901.732 |
|
|
|
|
|
|
TOTAL |
5271.130 |
3764.303 |
3102.476 |
|
|
|
|
|
|
II.
ASSETS |
|
|
|
|
(1)
Non-current assets |
|
|
|
|
(a) Fixed
Assets |
|
|
|
|
(i)
Tangible assets |
900.110 |
493.894 |
502.911 |
|
(ii)
Intangible Assets |
0.000 |
174.256 |
225.635 |
|
(iii)
Capital work-in-progress |
0.000 |
0.000 |
0.000 |
|
(iv)
Intangible assets under development |
0.000 |
0.000 |
0.000 |
|
(b) Non-current Investments |
676.160 |
676.164 |
676.164 |
|
(c) Deferred tax assets (net) |
0.000 |
0.000 |
0.000 |
|
(d) Long-term Loan and Advances |
8.260 |
15.006 |
12.021 |
|
(e) Other
Non-current assets |
0.000 |
0.000 |
0.000 |
|
Total Non-Current
Assets |
1584.530 |
1359.320 |
1416.731 |
|
|
|
|
|
|
(2)
Current assets |
|
|
|
|
(a)
Current investments |
0.000 |
0.000 |
0.000 |
|
(b)
Inventories |
510.250 |
556.086 |
513.176 |
|
(c) Trade
receivables |
1246.300 |
1123.797 |
914.188 |
|
(d) Cash
and cash equivalents |
1675.420 |
333.736 |
4.130 |
|
(e)
Short-term loans and advances |
254.630 |
391.364 |
254.251 |
|
(f) Other
current assets |
0.000 |
0.000 |
0.000 |
|
Total
Current Assets |
3686.600 |
2404.983 |
1685.745 |
|
|
|
|
|
|
TOTAL |
5271.130 |
3764.303 |
3102.476 |
PROFIT
& LOSS ACCOUNT
|
|
PARTICULARS |
31.03.2015 |
31.03.2014 |
31.03.2013 |
||
|
|
SALES |
|
|
|
||
|
|
|
Income |
4055.940 |
3149.446 |
1922.970 |
|
|
|
|
Other Income |
30.880 |
33.120 |
41.718 |
|
|
|
|
TOTAL (A) |
4086.820 |
3182.566 |
1964.688 |
|
|
|
|
|
|
|
||
|
Less |
EXPENSES |
|
|
|
||
|
|
|
Cost of Materials Consumed |
1935.640 |
1426.341 |
659.575 |
|
|
|
|
Purchase of Stock-in-trade |
232.330 |
288.372 |
275.531 |
|
|
|
|
Changes in Inventories of finished goods, work-in-progress and
stock-in-trade |
13.550 |
(18.406) |
91.931 |
|
|
|
|
Employee Benefits Expenses |
236.550 |
213.886 |
153.925 |
|
|
|
|
Other Expenses |
480.460 |
401.094 |
299.319 |
|
|
|
|
TOTAL (B) |
2898.530 |
2311.287 |
1480.281 |
|
|
|
|
|
|
|
||
|
|
PROFIT/(LOSS)
BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B) (C) |
1188.290 |
871.279 |
484.407 |
||
|
|
|
|
|
|
||
|
Less |
FINANCIAL
EXPENSES (D) |
131.130 |
152.127 |
101.323 |
||
|
|
|
|
|
|
||
|
|
PROFIT/(LOSS)
BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)
(E) |
1057.160 |
719.152 |
383.084 |
||
|
|
|
|
|
|
||
|
Less |
DEPRECIATION/
AMORTISATION (F) |
90.310 |
86.561 |
87.033 |
||
|
|
|
|
|
|
||
|
|
PROFIT/(LOSS)
BEFORE TAX (E-F) (G)
|
966.850 |
632.591 |
296.051 |
||
|
|
|
|
|
|
||
|
Less |
TAX (H) |
295.760 |
77.020 |
-99.777 |
||
|
|
|
|
|
|
||
|
|
PROFIT/(LOSS)
AFTER TAX (G-H) (I) |
671.090 |
555.571 |
395.828 |
||
|
|
|
|
|
|
||
|
|
EARNINGS IN FOREIGN
CURRENCY |
NA |
3117.026 |
1890.165 |
||
|
|
|
|
|
|
||
|
|
IMPORTS |
|
|
|
||
|
|
|
Raw Materials |
NA |
600.347 |
288.930 |
|
|
|
|
Capital Goods / Spares |
NA |
6.032 |
11.955 |
|
|
|
TOTAL IMPORTS |
NA |
606.379 |
300.885 |
||
|
|
|
|
|
|
||
|
|
Earnings Per
Share (Rs.) |
1.64 |
1.44 |
1.03 |
||
CURRENT MATURITIES OF LONG TERM DEBT DETAILS
|
Particulars |
31.03.2015 |
31.03.2014 |
31.03.2013 |
|
Current Maturities of Long term debt |
NA |
113.669 |
74.509 |
|
Cash generated from operations |
NA |
NA |
NA |
|
Net cash used in operating activities |
NA |
541.807 |
85.802 |
KEY
RATIOS
|
PARTICULARS |
|
31.03.2015 |
31.03.2014 |
31.03.2013 |
|
Net Profit Margin PAT / Sales |
(%) |
16.55 |
17.64 |
20.58 |
|
|
|
|
|
|
|
Operating Profit Margin (PBDIT/Sales) |
(%) |
29.30 |
27.66 |
25.19 |
|
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets) |
(%) |
21.04 |
20.48 |
12.20 |
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
0.27 |
0.40 |
0.27 |
|
|
|
|
|
|
|
Debt Equity Ratio (Total Debt /Networth) |
|
0.12 |
0.56 |
0.82 |
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
2.19 |
1.23 |
0.89 |
STOCK
PRICES
|
Face Value |
Rs.1.00/- |
|
Market Value |
Rs.107.30/- |
FINANCIAL ANALYSIS
[all figures are
in Rupees Million]
DEBT EQUITY RATIO
|
Particular |
31.03.2013 |
31.03.2014 |
31.03.2015 |
|
|
Rs.
In Million |
Rs.
In Million |
Rs. In
Million |
|
Share Capital |
520.307 |
520.307 |
534.310 |
|
Reserves & Surplus |
579.456 |
1078.892 |
3047.460 |
|
Net
worth |
1099.763 |
1599.199 |
3581.770 |
|
|
|
|
|
|
long-term borrowings |
78.768 |
198.154 |
0.000 |
|
Short term borrowings |
753.123 |
580.587 |
435.220 |
|
Total
borrowings |
831.891 |
778.741 |
435.220 |
|
Debt/Equity
ratio |
0.756 |
0.487 |
0.122 |
YEAR-ON-YEAR GROWTH
|
Year
on Year Growth |
31.03.2013 |
31.03.2014 |
31.03.2015 |
|
|
Rs.
In Million |
Rs.
In Million |
Rs.
In Million |
|
Sales |
1922.970 |
3149.446 |
4055.940 |
|
|
|
63.780 |
28.783 |
NET PROFIT MARGIN
|
Net
Profit Margin |
31.03.2013 |
31.03.2014 |
31.03.2015 |
|
|
Rs.
In Million |
Rs.
In Million |
Rs.
In Million |
|
Sales
|
1922.970 |
3149.446 |
4055.940 |
|
Profit |
395.828 |
555.571 |
671.090 |
|
|
20.58% |
17.64% |
16.55% |
LOCAL AGENCY FURTHER INFORMATION
|
Sr. No. |
Check list by
info agents |
Available in
Report (Yes/No) |
|
1 |
Year of establishment |
Yes |
|
2 |
Constitution of the entity -Incorporation
details |
Yes |
|
3 |
Locality of the entity |
Yes |
|
4 |
Premises details |
No |
|
5 |
Buyer visit details |
-- |
|
6 |
Contact numbers |
Yes |
|
7 |
Name of the person contacted |
No |
|
8 |
Designation of contact person |
No |
|
9 |
Promoter’s background |
Yes |
|
10 |
Date of Birth of Proprietor / Partners /
Directors |
Yes |
|
11 |
Pan Card No. of Proprietor / Partners |
No |
|
12 |
Voter Id Card No. of Proprietor / Partners |
No |
|
13 |
Type of business |
Yes |
|
14 |
Line of Business |
Yes |
|
15 |
Export/import details (if applicable) |
No |
|
16 |
No. of employees |
Yes |
|
17 |
Details of sister concerns |
Yes |
|
18 |
Major suppliers |
No |
|
19 |
Major customers |
No |
|
20 |
Banking Details |
Yes |
|
21 |
Banking facility details |
Yes |
|
22 |
Conduct of the banking account |
-- |
|
23 |
Financials, if provided |
Yes |
|
24 |
Capital in the business |
Yes |
|
25 |
Last accounts filed at ROC, if applicable |
Yes |
|
26 |
Turnover of firm for last three years |
Yes |
|
27 |
Reasons for variation <> 20% |
-- |
|
28 |
Estimation for coming financial year |
No |
|
29 |
Profitability for last three years |
Yes |
|
30 |
Major shareholders, if available |
Yes |
|
31 |
External Agency Rating, if available |
Yes |
|
32 |
Litigations that the firm/promoter
involved in |
Yes |
|
33 |
Market information |
-- |
|
34 |
Payments terms |
No |
|
35 |
Negative Reporting by Auditors in the
Annual Report |
No |
LITIGATION DETAILS:
|
HIGH COURT OF BOMBAY Bench:- Bombay |
|||||||
|
Lodging No:- |
SL/1147/2012 |
Filing Date:- |
26/04/2012 |
Reg. No.:- |
S/1585/2012 |
Reg. Date:- |
10/07/2012 |
|
Petitioner:- |
EMBEE DROAD SERVICES PRIVATE LIMITED |
Respondent:- |
MARKSANS PHARMA LIMITED |
||||
|
Petn. Adv.: |
S.V.VORA (0) |
||||||
|
District:- |
MUMBAI |
||||||
|
Bench:- |
SINGLE |
||||||
|
Status:- |
Transferred |
Category:- |
Civil Suits |
||||
|
Transfer Date: |
17/01/2013 |
Remark: |
Transferred to City Civil Court |
||||
|
Act:- |
Code of Civil Procedure 1908 |
||||||
CONTINGENT
LIABILITIES
|
Particulars |
|
31.03.2014 Rs. In Million |
|
Claims against the company not acknowledged as debt |
|
2.568 |
|
Guarantees and Letter of Credit |
|
834.230 |
|
Other money for which the company is contingently liable |
|
|
|
Sales Tax |
|
|
|
Sales Tax (BST, CST) - 03-04 |
|
0.506 |
|
Sales Tax (BST, CST) - 04-05 |
|
0.790 |
|
Sales Tax (CST) - 06-07 |
|
-- |
|
Foreign Currency Convertible Bonds |
|
-- |
|
|
|
838.094 |
UNAUDITED
FINANCIAL RESULTS FOR THE QUARTER ENDED 30TH JUNE 2015
(Rs. In Million)
|
Particulars |
Quarter Ended (Unaudited) |
|
|
30.06.2015 |
|
1.
Income from operations |
|
|
a) Net sales/ Income from operation (net of excise duty) |
1023.230 |
|
b) Other operating income |
22.990 |
|
Total
income from Operations(net) |
1046.220 |
|
2.Expenditure |
|
|
a) Cost of material consumed |
447.550 |
|
b) Purchases of stock in trade |
59.650 |
|
c) Changes in inventories of finished goods,
work-in-progress and stock-in-trade |
(17.730) |
|
d) Employees benefit expenses |
53.130 |
|
e) Depreciation and amortization expenses |
26.640 |
|
f) Other expenditure |
111.900 |
|
Total expenses |
681.140 |
|
3. Profit from operations before other income and
financial costs |
365.080 |
|
4. Other income |
-- |
|
5. Profit from ordinary activities before finance costs |
365.080 |
|
6. Finance costs |
23.810 |
|
7. Net profit/(loss) from ordinary activities
after finance costs but before exceptional items |
341.270 |
|
8. Exchange Currency Fluctuation Loss/ (Gain) |
-- |
|
9. Profit from ordinary activities before tax
Expense: |
341.270 |
|
10.Tax expenses |
102.500 |
|
11.Net Profit / (Loss) from
ordinary activities after tax (9-10) |
238.770 |
|
12.Extraordinary Items (net of tax expense) |
-- |
|
13.Net Profit / (Loss) for the period (11 -12) |
238.770 |
|
14.Paid-up equity share capital (Nominal value Rs.10/- per share) |
409.310 |
|
15. Reserve excluding Revaluation Reserves as per
balance sheet of previous accounting year |
|
|
16.i) Earnings per share (before extraordinary items)
of Rs.10/- each) (not annualised): |
|
|
Basic and diluted |
0.58 |
|
|
|
|
A. Particulars of shareholding |
|
|
1. Public Shareholding |
|
|
- Number of shares |
211821965 |
|
- Percentage of shareholding |
51.75% |
|
2. Promoters and Promoters group Shareholding- |
197491733 |
|
a) Pledged /Encumbered |
|
|
Number of shares |
NIL |
|
Percentage of shares (as a % of total shareholding of the
promoter and promoter group) |
NIL |
|
Percentage of shares (as a % of total share capital of the
company) |
NIL |
|
|
|
|
b) Non Encumbered |
|
|
Number of shares |
197491733 |
|
Percentage of shares (as a % of total shareholding of the
promoter and promoter group) |
100.00% |
|
Percentage of shares (as a % of total share capital of the
company) |
48.25% |
|
|
|
|
B.
Investor Complaints |
|
|
Pending at the beginning of the quarter |
0 |
|
Receiving during the quarter |
4 |
|
Disposed of during the quarter |
4 |
|
Remaining unreserved at the end of the quarter |
0 |
INDEX OF CHARGE:
|
Sr. No. |
Charge ID |
Date of Charge
Creation/Modification |
Charge amount
secured |
Charge Holder |
Address |
Service Request
Number (SRN) |
|
1 |
10241328 |
13/08/2010 |
60,000,000.00 |
Bank of India |
Mumbai MID Corporate, 70/80, M.G. Road,, Bank of India Building, Mezzanine Floor, Fort, Mumbai, Maharashtra - 400001, India |
A93860021 |
|
2 |
80034914 |
12/01/2015 * |
2,200,000,000.00 |
State Bank of India |
Corporate Account Group Branch, Nevile House, J.N. Heredia Marg, Ballard Estate, Mumbai, Maharashtra - 400001, India |
C41039587 |
*Date of modification Charges
FIXED ASSETS:
·
Land
·
Building
·
Plant and Machinery
·
Computer and Software
·
Office Equipments
·
Furniture and Fixtures
·
Vehicles
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No exist to suggest that subject is or was
the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or investigation
registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No available
information exist that suggest that subject or any of its principals have been
formally charged or convicted by a competent governmental authority for any
financial crime or under any formal investigation by a competent government
authority for any violation of anti-corruption laws or international anti-money
laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.64.17 |
|
|
1 |
Rs.99.85 |
|
Euro |
1 |
Rs.70.36 |
INFORMATION DETAILS
|
Information
Gathered by : |
GYT |
|
|
|
|
Analysis Done by
: |
RAS |
|
|
|
|
Report Prepared
by : |
NKT |
SCORE & RATING EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
6 |
|
PAID-UP CAPITAL |
1~10 |
5 |
|
OPERATING SCALE |
1~10 |
7 |
|
FINANCIAL
CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
7 |
|
--PROFITABILITY |
1~10 |
6 |
|
--LIQUIDITY |
1~10 |
5 |
|
--LEVERAGE |
1~10 |
5 |
|
--RESERVES |
1~10 |
6 |
|
--CREDIT LINES |
1~10 |
6 |
|
--MARGINS |
-5~5 |
--- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
YES |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
NO |
|
--AFFILIATION |
YES/NO |
YES |
|
--LISTED |
YES/NO |
YES |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
DEFAULTER
|
|
|
|
--RBI |
YES/NO |
NO |
|
--EPF |
YES/NO |
NO |
|
|
|
|
|
TOTAL |
|
53 |
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is calculated
from a composite of weighted scores obtained from each of the major sections of
this report. The assessed factors and their relative weights (as indicated
through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment record
(10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NB |
NEW BUSINESS |
||
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.